Good post. The eco system is about building a strong foundation...

First 102 Last

Share
Profile

Follow
manny100

5,406 Posts.

2351

03/01/24

22:30

Post #: 71716390
Share

Originally posted by Kachoo: ↑

I do not know when any announcements will be made publicly. This is what I know.

All the partners and eco system they have built exceed anything they had going back when the SP was 17.5 cents last time.

They have revenue that should come down the pipe through various announcements they have provided.

How much revenue we do not know or can project. This I can say if BRN was to make even 20 Million this year theg would likely still do a raise. The will need to Tape out Akida 2.0 and down the road 3.0 as it has been stated many customers want to see it on chip.

The only negative difference that I see from the SP 4 years back and today is the negativity surrounding these chats atm. This has enabled the institutions to increase positions while the common retail investor has been scared away taking the punt. So positive outlooks are really suppressed.

Games are played with stocks all the time that is normal. Stocks over shoot and undershoot true values one will need to decide if we are above or below true value and what the future will bring.

The tools and resources institutions have is beyond retail capabilities they have investor meeting Intel in every corner of each industry. They have expensive broker reports that research beyond what the 1000 eyes can do lol.

if I see institutions increase positions while smashing a pre revenue stock they see value so maybe I need to clear the fog.

Has the company and management screwed up lots IMO absolutely but they have also done quite a bit of growth in the business model. We know Neuromorphic computing is growing and there will be a few companies that will sell this architecture so like some say we will become obsolete is likely incorrect SNN has barely started. At this time many solutions are still old vonneumann systems.

so to me today's news BRN basicly says they can sell the CR shares at about 70% higher then what prices are today. Is that a good return on money if you got 70% i would think yes. They are also calling this a minumin.

before they said the SP will do what the SP will do Today they out out that the SP will be 70 % higher then it is today. What will drive that IP deals Revenue growth or both.

If we have 2 IP deals and see about 10 million revenue for the year what would the SP be? I can't answer that but I would say north of what BRN are calling the minumin .

Expand

Good post. The eco system is about building a strong foundation for when demand accelerates.
Partners know demand will pick up that is why they ensuring AKIDA works well with them and jointly presenting etc.

BRN Price at posting: 17.5¢ Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

NOX

Noxopharm aims for autoimmune market with first human trial of SOF-SKN

SMI

Gold intercept of 8.6 g/t continues the positive storyline for Santana at NZ's RAS deposit

PR1

Fourfold skarn increase points the way to viable garnet project, says Pure

Good habits matters when it comes to finances

Earnings wrap Monday Week 34: A2 Milk, Bluescope, Suncorp's climate woes & more

There are more pages in this discussion • 6 more messages in this thread...

First 102 Last

Add BRN (ASX) to my watchlist

(20min delay)
Last 18.0¢		Change -0.010(5.26%)		Mkt cap ! $352.6M

Open	High	Low	Value	Volume
19.0¢	19.0¢	17.5¢	$807.2K	4.454M

Buyers (Bids)

No.	Vol.	Price($)
47	1828984	17.5¢

Sellers (Offers)

Price($)	Vol.	No.
18.5¢	514555	7

View Market Depth

No.	Vol.	Price($)
47	1828984	0.175
80	2842088	0.170
56	1758313	0.165
72	1659060	0.160
25	1075643	0.155

Price($)	Vol.	No.
0.185	514555	7
0.190	525010	16
0.195	935641	16
0.200	964194	41
0.205	962425	11

Last trade - 16.10pm 19/08/2024 (20 minute delay)

BRN (ASX) Chart

Good post. The eco system is about building a strong foundation...

Noxopharm aims for autoimmune market with first human trial of SOF-SKN

Gold intercept of 8.6 g/t continues the positive storyline for Santana at NZ's RAS deposit

Fourfold skarn increase points the way to viable garnet project, says Pure

Good habits matters when it comes to finances

Earnings wrap Monday Week 34: A2 Milk, Bluescope, Suncorp's climate woes & more

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Good post. The eco system is about building a strong foundation...

Top Stories

Noxopharm aims for autoimmune market with first human trial of SOF-SKN

Gold intercept of 8.6 g/t continues the positive storyline for Santana at NZ's RAS deposit

Fourfold skarn increase points the way to viable garnet project, says Pure

Good habits matters when it comes to finances

Earnings wrap Monday Week 34: A2 Milk, Bluescope, Suncorp's climate woes & more

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News